KALV earnings: a positive outcome, +9.7%

On July 7, 2022, KalVista Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.7% in the window around the event. It had already run +11.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.